| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |